79 related articles for article (PubMed ID: 25576221)
1. Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis.
Hu J; Feng F; Zhu S; Sun L; Li G; Jiang N; Shang Z; Niu Y
Gene; 2015 Mar; 558(2):265-70. PubMed ID: 25576221
[TBL] [Abstract][Full Text] [Related]
2. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
3. The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis.
Shen Y; Li D; Tian P; Shen K; Zhu J; Feng M; Wan C; Yang T; Chen L; Wen F
Medicine (Baltimore); 2015 Apr; 94(13):e679. PubMed ID: 25837760
[TBL] [Abstract][Full Text] [Related]
4. Catalase gene C-262T polymorphism: importance in ulcerative colitis.
Khodayari S; Salehi Z; Fakhrieh Asl S; Aminian K; Mirzaei Gisomi N; Torabi Dalivandan S
J Gastroenterol Hepatol; 2013 May; 28(5):819-22. PubMed ID: 23425094
[TBL] [Abstract][Full Text] [Related]
5. Human catalase gene polymorphism (CAT C-262T) and risk of male infertility.
Sabouhi S; Salehi Z; Bahadori MH; Mahdavi M
Andrologia; 2015 Feb; 47(1):97-101. PubMed ID: 24456074
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of catalase gene (CAT C-262T) in women with endometriosis.
Zarafshan SS; Salehi Z; Salahi E; Sabet EE; Shabanipour S; Zahiri Z
J Obstet Gynaecol; 2015 Apr; 35(3):269-71. PubMed ID: 25154023
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of eNOS, catalase, and myeloperoxidase genes in prostate cancer in Turkish men: preliminary results.
Ceylan GG; Ceylan C; Gülmemmedov B; Tonyalı Ş; Odabaş O; Gözalan A; Keleş I; Öztürk E
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706591
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
[TBL] [Abstract][Full Text] [Related]
9. IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
Shao N; Xu B; Mi YY; Hua LX
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768
[TBL] [Abstract][Full Text] [Related]
10. ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.
Xu B; Tong N; Li JM; Zhang ZD; Wu HF
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):270-7. PubMed ID: 20231859
[TBL] [Abstract][Full Text] [Related]
11. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
Li XL; Xu JH
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):244-9. PubMed ID: 22370724
[TBL] [Abstract][Full Text] [Related]
12. [Modulation of apoptosis in mononuclear cells with different variants of polymorphism C-262T in catalase gene].
Komina AV; Ruksha TG
Tsitologiia; 2014; 56(8):599-603. PubMed ID: 25697005
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
[TBL] [Abstract][Full Text] [Related]
14. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
Wang C; Tao W; Chen Q; Hu H; Wen XY; Han R
Prostate; 2010 Feb; 70(2):170-8. PubMed ID: 19760631
[TBL] [Abstract][Full Text] [Related]
15. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.
Zhang HT; Xu Y; Zhang ZH; Li L
Genet Mol Res; 2012 Jun; 11(2):1642-50. PubMed ID: 22782583
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients.
Mak JC; Leung HC; Ho SP; Ko FW; Cheung AH; Ip MS; Chan-Yeung MM
Clin Exp Allergy; 2006 Apr; 36(4):440-7. PubMed ID: 16630148
[TBL] [Abstract][Full Text] [Related]
18. TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis.
Cai Q; Tang Y; Zhang M; Shang Z; Li G; Tian J; Jiang N; Quan C; Niu Y
Tumour Biol; 2014 Jan; 35(1):667-73. PubMed ID: 23975370
[TBL] [Abstract][Full Text] [Related]
19. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
20. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients.
Chistiakov DA; Zotova EV; Savost'anov KV; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
Diabetes Metab; 2006 Feb; 32(1):63-8. PubMed ID: 16523188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
